Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Cosmetics Order

10 Nov 2008 07:00

RNS Number : 7233H
Timestrip PLC
10 November 2008
 

Timestrip plc ("Timestrip")

Cosmetics Order

Timestrip plc is delighted to announce that it has received its first order to supply

its patented Timestrip product into the Cosmetics sector.

The deal involves the full integration of the Timestrip into the packaging of a branded cosmetics product that will be launched in 2009 throughout the US and in selected outlets in Europe. Confidentiality restrictions prevent disclosure of the identity of the brand, product or leading beauty retail chain through which the product will be sold, until closer to launch.

Known as a "Period After Opening" instruction, all cosmetic products sold in the EU with a shelf life over 30 months have to show for how long the product can be safely used after opening. Governed by the EU Cosmetics Directive, this is currently satisfied by printing a line drawn symbol of an open jar with a number (of months) on the product's label, which is fast becoming accepted as best practice worldwide.

In recent months Timestrip was featured in a number of leading U.S. women's magazines culminating in television segments on both the Today Show and NBC News. This media attention focused on Timestrip as a solution for keeping track of the age of beauty products and highlights a growing consumer awareness of this issue. Timestrips are unique in their ability to go further than a simple printed instruction, as they show when the limit on that recommended storage time has actually been reached, by virtue of the coloured liquid reaching the end of the window.

Reuben Isbitsky, Joint Chief Executive, Timestrip Plc, commented: "This deal is important for a number of reasons. Not only have we have broken into a potentially lucrative sector that is governed by legislation, but we will also be able to showcase a full integration of our technology into the packaging of a mass-market product that is both aesthetically pleasing and extremely functional. We aim to establish Timestrip in the Beauty and Cosmetics sector in the same way that we are fast becoming a technology of choice in the Appliance/Consumables market worldwide."

For more information, please contact:

Paul Freedman, Joint CEO, Timestrip plc 01462 440 700

Geoff Nash, FinnCap, NOMAD 020 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUUGQUGUPRGWM
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.